BioCentury
ARTICLE | Clinical News

Ravicti glycerol phenylbutyrate: Postmarketing study started

November 11, 2013 8:00 AM UTC

Hyperion began the THRIVE patient registry study to evaluate standard of care treatments, including ammonia-scavenging agents Ravicti, sodium phenylbutyrate or sodium benzoate, in up to 500 patients w...